Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amicus (FOLD – Research Report), Cardinal Health (CAH – Research Report) and Nektar Therapeutics (NKTR – Research Report).
Amicus (FOLD)
In a report issued on August 11, Anupam Rama from J.P. Morgan maintained a Buy rating on Amicus, with a price target of $16.00. The company’s shares closed last Monday at $12.37, close to its 52-week high of $12.76.
According to TipRanks.com, Rama is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Amicus with a $14.25 average price target, which is a 16.9% upside from current levels. In a report issued on August 5, SVB Securities also reiterated a Buy rating on the stock with a $16.00 price target.
See today’s best-performing stocks on TipRanks >>
Cardinal Health (CAH)
In a report issued on August 12, Lisa Gill from J.P. Morgan maintained a Hold rating on Cardinal Health, with a price target of $68.00. The company’s shares closed last Monday at $69.97, close to its 52-week high of $71.45.
According to TipRanks.com, Gill is a 5-star analyst with an average return of
Currently, the analyst consensus on Cardinal Health is a Hold with an average price target of $67.00, implying a -2.7% downside from current levels. In a report issued on August 11, Mizuho Securities also maintained a Hold rating on the stock with a $66.00 price target.
Nektar Therapeutics (NKTR)
Nektar Therapeutics received a Sell rating from J.P. Morgan analyst Jessica Fye yesterday. The company’s shares closed last Monday at $4.91, close to its 52-week low of $3.02.
According to TipRanks.com, Fye is a 4-star analyst with an average return of
Nektar Therapeutics has an analyst consensus of Hold, with a price target consensus of $4.74.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on FOLD:
- PainReform Provides Business Update for the Second Quarter of 2022
- MJ Holdings Inc.’s Amargosa Farm Receives Approval from NYE County to Grow
- TERRA BALCANICA ANNOUNCES RESULTS OF 2022 ANNUAL GENERAL MEETING AND APPOINTS NEW DIRECTOR
- Frontera Commences Sales and Marketing Efforts, Announces Business Updates
- Krishna Vanka Joins Fluence as Senior Vice President and Chief Digital Officer to Scale the Strategic Growth of Fluence’s SaaS Business
